Grcevska L, Polenakovic M
Department of Nephrology, Faculty of Medicine, Skopje, Republic of Macedonia.
Ren Fail. 1995 Sep;17(5):595-604. doi: 10.3109/08860229509037624.
Over a period of 5 years, we observed 28 patients with biopsy-proven crescentic glomerulonephritis. Four of these patients were ANCA associated (pauci immune), 1 had anti-glomerular basement membrane antibodies (anti-GBM), and the other 23 cases had immune complex form (22 poststreptococcal and 1 poststaphylococcal). Acute renal failure as a main clinical feature was found in 11/28 (35.7%), all with more than 80% crescents, including all ANCA-associated cases, anti-GBM form, and the patient with poststaphylococcal form. Using "pulse" therapy with methylprednisolone, cyclophosphamide, and plasmapheresis, renal function was improved in 5/11 (45.4%), diuresis started, and end-stage renal disease was delayed. The therapy was continued orally with steroids and cyclophosphamide. The second attach of oligoanuria developed after a period of 6-12 months without improvement after the therapy used previously (during the first attack), and it was necessary to begin chronic hemodialysis treatment.
在5年的时间里,我们观察了28例经活检证实为新月体性肾小球肾炎的患者。其中4例患者为ANCA相关性(少免疫性),1例有抗肾小球基底膜抗体(抗GBM),另外23例为免疫复合物型(22例为链球菌感染后,1例为葡萄球菌感染后)。11/28(35.7%)的患者以急性肾衰竭为主要临床特征,所有这些患者的新月体均超过80%,包括所有ANCA相关性病例、抗GBM型以及葡萄球菌感染后型的患者。采用甲泼尼龙、环磷酰胺和血浆置换的“冲击”疗法,5/11(45.4%)的患者肾功能得到改善,开始利尿,终末期肾病得以延缓。治疗继续口服类固醇和环磷酰胺。在先前治疗(首次发作期间)后6至12个月没有改善的一段时间后,少尿再次发作,有必要开始慢性血液透析治疗。